Qitan Technology
Qitan Technology is a Chengdu-based biotech that develops and manufactures nanopore-based gene sequencers — including China's first domestically produced nanopore platform (QNome) — and sells them to Chinese research laboratories, academic institutions, and clinical genomics customers.
- Company typePrivate
- Founded2016
- HeadquartersChengdu, China
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
Qitan Technology firmographics
Firmographics- Name
- Qitan Technology
- Legal name
- Qitan Technology
- Website
- https://qitantech.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Qitan Technology is a Chengdu-based biotech that develops and manufactures nanopore-based gene sequencers — including China's first domestically produced nanopore platform (QNome) — and sells them to Chinese research laboratories, academic institutions, and clinical genomics customers.
- Ownership category
- akta.pro rank
Qitan Technology industry classification
Industry- Product category
- Genomics Sequencing Instruments
- akta.pro primary industry
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
Keywords
Where Qitan Technology is headquartered
LocationHeadquarters
- HQ city
- Chengdu
- HQ country
- China
- HQ region
- Asia
Offices1 record
Markets served
Qitan Technology business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Revenue model
- Gene sequencing hardware sales: Qitan Technology generates revenue through the sale of nanopore gene sequencers. The company develops and manufactures fourth-generation sequencing equipment, with plans for mass production of domestically developed nanopore gene sequencers targeting laboratories and research institutions.
- R&D and product development services: The company engages in R&D and product development activities for nanopore gene sequencing technology, which may include professional services, custom development, or technology licensing components.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Qitan Technology product offering
Product offeringCore offering
Qitan Technology develops and manufactures nanopore gene sequencers for DNA/RNA sequencing applications. The company offers its QNome nanopore sequencing platform along with a fourth-generation gene sequencer designed to be competitively priced to reduce sequencing costs for laboratories and research institutions. As China's first domestically developed nanopore gene sequencer manufacturer, the company is positioned in the next-generation gene sequencing market.
Differentiator
Problem solved
Functional benefit
Products and services
- QNome Nanopore Gene Sequencing Platform The QNome nanopore gene sequencing platform developed by Qitan Technology for DNA/RNA sequencing applications in research and clinical laboratory settings.
- Nanopore Gene Sequencer (First Domestically Developed) China's first domestically developed nanopore gene sequencer, utilizing nanopore-based DNA sequencing technology for genetic analysis. Targeted at laboratories and research institutions for genomic research and clinical applications.
- Fourth-Generation Gene Sequencer Next-generation nanopore gene sequencer designed to be competitively priced and significantly reduce costs for laboratories requiring gene sequencing equipment.
Quantifiable outcome
- Significantly reduce costs for laboratories through competitively priced fourth-generation gene sequencer
Companies that use Qitan Technology
Customer profileSegments1 record
Ideal customer profiles1 record
Qitan Technology technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Qitan Technology partnerships and signals
Strategic signalScale indicators5 records
Qitan Technology competitors and assessment
Company assessmentDirect peers
- Oxford Nanopore Technologies: Global pioneer and leader in nanopore-based sequencing (MinION, GridION, PromethION). Most directly comparable to Qitan as the original nanopore sequencing company targeting similar research and clinical use cases.
- BGI Group: China-based genomics giant with significant domestic sequencing instrument manufacturing (including via MGI Tech) and large installed base of sequencers across Chinese research and clinical labs—Qitan's most direct domestic rival.
- MGI Tech: BGI-affiliate developing DNBSEQ sequencing platforms; competes head-to-head in the Chinese sequencer market with Qitan on cost and performance for laboratory customers.
Broad incumbents
- Illumina: Dominant short-read sequencing incumbent with global installed base; competes in the broader DNA sequencing market Qitan addresses and sets the benchmark for performance and pricing pressure.
- Pacific Biosciences: Long-read sequencing competitor (HiFi reads via SMRT technology) competing with nanopore in high-accuracy long-read applications such as whole-genome assembly and clinical research.
- Thermo Fisher Scientific: Life sciences tools giant offering sequencing through the Ion Torrent platform and adjacent genomic analysis instruments; broad incumbent with overlapping capabilities rather than a nanopore specialist.
- Roche (Genentech Diagnostics / Sequencing): Global diagnostics and sequencing player with nanopore-related investments and clinical sequencing ambitions; broader portfolio competitor with relevant sequencing overlap.
Emerging players
- Element Biosciences: Emerging sequencing platform developer (AVITI) targeting lower-cost benchtop sequencers; competes on price-performance for the same research-lab customer base Qitan targets.
- Singular Genomics: Developer of the G4 benchtop sequencer, positioning as a low-cost alternative to Illumina in research settings—directly comparable to Qitan's cost-competitive laboratory sequencer strategy.
- GenapSys: Early-stage developer of a low-cost, benchtop electronic sequencing platform; niche overlap with Qitan on affordable sequencers for smaller laboratories.
Market position
Customer concentration
Qitan Technology social profiles
Digital presenceQitan Technology financial estimates
Financial estimateRevenue estimate
Valuation estimate
Qitan Technology leadership team
Management profileNumber of profiles
Profiles4 records
Qitan Technology funding detail
Funding detailFunding overview
Funding rounds7 records
Investors17 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Qitan Technology M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Qitan Technology
What does Qitan Technology do?
Qitan Technology develops and manufactures nanopore gene sequencers for DNA/RNA sequencing applications. The company offers its QNome nanopore sequencing platform along with a fourth-generation gene sequencer designed to be competitively priced to reduce sequencing costs for laboratories and research institutions. As China's first domestically developed nanopore gene sequencer manufacturer, the company is positioned in the next-generation gene sequencing market.
Is Qitan Technology a public or private company?
Qitan Technology is a private company. It is classified as venture growth investor backed and is currently operating.
When was Qitan Technology founded?
Qitan Technology was founded in 2016. It employs 51 to 100 people.
Where is Qitan Technology based?
Qitan Technology is headquartered in Chengdu, China, in the Asia region.
How does Qitan Technology make money?
Two revenue lines are on record. Gene sequencing hardware sales are the primary driver. The others are R&D and product development services.
Who are Qitan Technology's main competitors?
Direct peers on record are Oxford Nanopore Technologies, BGI Group and MGI Tech. Broad incumbents are Illumina, Pacific Biosciences, Thermo Fisher Scientific and Roche (Genentech Diagnostics / Sequencing). Emerging players are Element Biosciences, Singular Genomics and GenapSys.
Does Qitan Technology have an API?
No public API is recorded for Qitan Technology.
What industry is Qitan Technology in?
Qitan Technology's product category is Genomics Sequencing Instruments. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays).